Repeated reserpine treatment alters firing pattern and responses of substantia nigral dopamine neurons. 1993

B C Sun, and K X Huang, and G Z Jin
Department of Pharmacology II, Shanghai Institute of Materia Medica, Chinese Academy of Sciences.

Repeated reserpine treatment (1 mg/kg x 6 days) increased the number of spontaneously active substantia nigra pars compacta (SNC) dopamine (DA) cells and altered the firing pattern to a more irregular one in locally anesthetized rats. The selective DA D1 receptor agonist, SKF 38393, although having little effect on SNC DA cells in normal rats, profoundly inhibited the firing rate of SNC DA cells in reserpinized rats. On the contrary, the DA D2 receptor agonist, N-0437, significantly inhibited the firing rate of SNC DA cells in control rats, however, the inhibition was not significantly altered by reserpine. The inhibitory effect of the mixed DA receptor agonist, apomorphine, was significantly enhanced after reserpine treatment. In addition, the inhibition of SNC DA cell firing produced by D1 and D2 receptor agonists in reserpinized rats was reversed only by their own subtype antagonists. These results suggest that repeated reserpine treatment renders SNC DA cells responsive to D1 receptor stimulation, and that D1 receptors play a more important role than D2 receptors in the supersensitivity of SNC DA cells induced by repeated reserpine treatment. The results also indicate that D1 and D2 receptor agonists inhibit SNC DA cell firing separately and synergically in reserpinized rats.

UI MeSH Term Description Entries
D008297 Male Males
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D012110 Reserpine An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use. Raunervil,Raupasil,Rausedil,Rausedyl,Serpasil,Serpivite,V-Serp,V Serp
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras
D015259 Dopamine Agents Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. Dopamine Drugs,Dopamine Effect,Dopamine Effects,Dopaminergic Agents,Dopaminergic Drugs,Dopaminergic Effect,Dopaminergic Effects,Agents, Dopamine,Agents, Dopaminergic,Drugs, Dopamine,Drugs, Dopaminergic,Effect, Dopamine,Effect, Dopaminergic,Effects, Dopamine,Effects, Dopaminergic
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

B C Sun, and K X Huang, and G Z Jin
November 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience,
B C Sun, and K X Huang, and G Z Jin
November 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience,
B C Sun, and K X Huang, and G Z Jin
November 1993, Synapse (New York, N.Y.),
B C Sun, and K X Huang, and G Z Jin
January 1996, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
B C Sun, and K X Huang, and G Z Jin
November 2002, Journal of theoretical biology,
B C Sun, and K X Huang, and G Z Jin
October 2009, Journal of neurophysiology,
B C Sun, and K X Huang, and G Z Jin
December 2009, The Journal of neuroscience : the official journal of the Society for Neuroscience,
B C Sun, and K X Huang, and G Z Jin
January 1998, Advances in pharmacology (San Diego, Calif.),
B C Sun, and K X Huang, and G Z Jin
September 1999, Journal of neurophysiology,
Copied contents to your clipboard!